MediPurpose Announces 28G Safety Lancet Online Survey

Qualified Submissions to Earn Entry for Amazon Kindle Drawing.

Atlanta, GA, November 03, 2011 --(PR.com)-- MediPurpose(r), a master distributor and manufacturer of medical products, today announced a new online survey for healthcare professionals to share their perspectives about 28-gauge (28G) safety lancet usage and preferences.

Participants that submit approved surveys will be entered into a drawing for an Amazon Kindle.

The online survey will be conducted now through November 9, 2011. Survey results and the drawing winner will be announced later in the month.

MediPurpose, which manufactures and distributes the popular SurgiLance(r) safety lancet, is conducting the survey to further validate its extensive research about market requirements as it moves forward with the development of a new 28G product that will meet its customers' exacting needs.

"There are a variety of 28G safety lancet configurations with varying depths present in the medical device market," said MediPurpose President and CSO Randy Prather. "Rather than to simply mimic the market trends, we feel it is important to reach out to our existing customer base to ensure that the available products meet all of their needs. This survey is an opportunity for users to provide MediPurpose with valuable input on a new medical product."

The SurgiLance safety lancet portfolio currently features six models:

-- SLN100, a 26-gauge safety lancet with a penetration depth of 1.0 mm.
-- SLN200, a 23-gauge safety lancet with a penetration depth of 1.8 mm.
-- SLN240, a 22-gauge safety lancet with a penetration depth of 2.2 mm.
-- SLN300, a 21-gauge safety lancet with a penetration depth of 2.8 mm.
-- SLB200, a 19-gauge safety lancet with a penetration depth of 1.8 mm.
-- SLB250, an 18-gauge safety lancet with a penetration depth of 2.3 mm.

MediPurpose also offers babyLance(r) heel sticks, a solution for neonatal blood collection that also provide the same safety, comfort and ease of use as SurgiLance. Both SurgiLance and babyLance have received U.S. FDA 510(k) clearance.

To participate in the survey please visit http://medipurpose.wufoo.com/forms/m7p8p5/.

For more information about SurgiLance -- including no-cost product sample requests -- please visit http://www.medipurpose.com/surgilance.

About MediPurpose

Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular babyLance(r) heel incision device, SurgiLance(r) safety lancet and MediPlus(tm) advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.

MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.

For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com.

###
Contact
MediPurpose
Derek Rudnak
888-808-6494
www.medipurpose.com
ContactContact
Categories